Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | 17-AAG | FIMM | pan-cancer | AAC | 0.066 | 0.7 |
mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | 0.011 | 0.7 |